Evogene (Israel) Investor Sentiment

EVGN Stock  ILA 583.60  16.20  2.70%   
About 61% of Evogene's investor base is looking to short. The analysis of current outlook of investing in Evogene suggests that many traders are alarmed regarding Evogene's prospects. The current market sentiment, together with Evogene's historical and current headlines, can help investors time the market. In addition, many technical investors use Evogene stock news signals to limit their universe of possible portfolio assets.
  
few days ago at news.google.com         
Evogene Sees Revenue Growth and Expands AI Collaboration - TipRanks
Google News at Macroaxis
six days ago at news.google.com         
A Glimpse of Evogenes Earnings Potential - Benzinga
Google News at Macroaxis
over a week ago at news.google.com         
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Followi...
Google News at Macroaxis
over three weeks ago at news.google.com         
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Nove...
Google News at Macroaxis
over a month ago at news.google.com         
Evogene Stock Crosses Below 200-Day Moving Average - Should You Sell - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Evogene Now Covered by StockNews.com - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of MicroFerment...
Google News at Macroaxis
over two months ago at news.google.com         
Evogene stock hits 52-week low at 2.6 amid market challenges - Investing.com
Google News at Macroaxis
over two months ago at news.google.com         
Evogene Receives New Coverage from Analysts at StockNews.com - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Evogene Ltd. Reports Mid-Year Financial Dip - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
EVGN - Evogene Ltd. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over three months ago at news.google.com         
Lake Street Capital Lowers Evogene Price Target to 12.00 - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Evogene rises on better Q2 results - XM
Google News at Macroaxis
over three months ago at news.google.com         
Evogene Now Covered by Analysts at StockNews.com - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Evogene Schedules Second Quarter 2024 Financial Results Release - StockTitan
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Evogene that are available to investors today. That information is available publicly through Evogene media outlets and privately through word of mouth or via Evogene internal channels. However, regardless of the origin, that massive amount of Evogene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Evogene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Evogene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Evogene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Evogene alpha.

Evogene Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Evogene Stock analysis

When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios